Antibodies in healthcare personnel following severe acute respiratory syndrome coronavirus virus 2 (SARS-CoV-2) infection

In a prospective cohort of healthcare personnel (HCP), we measured severe acute respiratory syndrome coronavirus virus 2 (SARS-CoV-2) nucleocapsid IgG antibodies after SARS-CoV-2 infection. Among 79 HCP, 68 (86%) were seropositive 14-28 days after their positive PCR test, and 54 (77%) of 70 were ser...

Full description

Saved in:
Bibliographic Details
Published in:Antimicrobial stewardship & healthcare epidemiology : ASHE 2022, Vol.2 (1), p.e93-e93, Article e93
Main Authors: Bosserman, Rachel E, Farnsworth, Christopher W, O'Neil, Caroline A, Cass, Candice, Park, Daniel, Ballman, Claire, Wallace, Meghan A, Struttmann, Emily, Stewart, Henry, Arter, Olivia, Peacock, Kate, Fraser, Victoria J, Budge, Philip J, Olsen, Margaret A, Burnham, Carey-Ann D, Babcock, Hilary M, Kwon, Jennie H
Format: Article
Language:English
Subjects:
Concise Communication
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c450t-50e95a84480f0a0ae8397bc78957d2606d28b44612aa9e7afff2721953aa4dc63
cites cdi_FETCH-LOGICAL-c450t-50e95a84480f0a0ae8397bc78957d2606d28b44612aa9e7afff2721953aa4dc63
container_end_page e93
container_issue 1
container_start_page e93
container_title Antimicrobial stewardship & healthcare epidemiology : ASHE
container_volume 2
creator Bosserman, Rachel E
Farnsworth, Christopher W
O'Neil, Caroline A
Cass, Candice
Park, Daniel
Ballman, Claire
Wallace, Meghan A
Struttmann, Emily
Stewart, Henry
Arter, Olivia
Peacock, Kate
Fraser, Victoria J
Budge, Philip J
Olsen, Margaret A
Burnham, Carey-Ann D
Babcock, Hilary M
Kwon, Jennie H
description In a prospective cohort of healthcare personnel (HCP), we measured severe acute respiratory syndrome coronavirus virus 2 (SARS-CoV-2) nucleocapsid IgG antibodies after SARS-CoV-2 infection. Among 79 HCP, 68 (86%) were seropositive 14-28 days after their positive PCR test, and 54 (77%) of 70 were seropositive at the 70-180-day follow-up. Many seropositive HCP (95%) experienced an antibody decline by the second visit.
doi_str_mv 10.1017/ash.2022.231
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_9b04a25b79924f0fa6e2770940fd9882</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_9b04a25b79924f0fa6e2770940fd9882</doaj_id><sourcerecordid>2753308057</sourcerecordid><originalsourceid>FETCH-LOGICAL-c450t-50e95a84480f0a0ae8397bc78957d2606d28b44612aa9e7afff2721953aa4dc63</originalsourceid><addsrcrecordid>eNpVkU1r3DAQhk1paUKaW8_FxxTqrTySLelSWJZ-BAKFpi29ibE82lXwSlvJ3rL_vt5uGpKLJGZenhn0FMXrmi1qVsv3mDcLYAAL4PWz4hwkh0po8ev5o_dZcZnzHWMMVM2kli-LM94KxXnLz4vDMoy-i72nXPpQbgiHcWMxUbmjlGMINJQuDkP848O6zLSnuYV2GqlMlHc-4RjTocyH0Ke4pdLGFAPufZpyeTqhvLpdfrutVvFnBW_nIY7s6GN4VbxwOGS6vL8vih-fPn5ffaluvn6-Xi1vKisaNlYNI92gEkIxx5AhKa5lZ6XSjeyhZW0PqhOirQFRk0TnHEiodcMRRW9bflFcn7h9xDuzS36L6WAievOvENPaYBq9HcjojgmEppNag3DMYUsgJdOCuV4rBTPrw4m1m7ot9ZbCmHB4An3aCX5j1nFvtIT5y4_LXN0DUvw9UR7N1mdLw4CB4pQNyIZzplgj5-i7U9SmmHMi9zCmZuYo38zyzVG-meXP8TePV3sI_1fN_wLe26wa</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2753308057</pqid></control><display><type>article</type><title>Antibodies in healthcare personnel following severe acute respiratory syndrome coronavirus virus 2 (SARS-CoV-2) infection</title><source>Open Access: PubMed Central</source><source>Cambridge Journals Online</source><source>Publicly Available Content Database</source><creator>Bosserman, Rachel E ; Farnsworth, Christopher W ; O'Neil, Caroline A ; Cass, Candice ; Park, Daniel ; Ballman, Claire ; Wallace, Meghan A ; Struttmann, Emily ; Stewart, Henry ; Arter, Olivia ; Peacock, Kate ; Fraser, Victoria J ; Budge, Philip J ; Olsen, Margaret A ; Burnham, Carey-Ann D ; Babcock, Hilary M ; Kwon, Jennie H</creator><creatorcontrib>Bosserman, Rachel E ; Farnsworth, Christopher W ; O'Neil, Caroline A ; Cass, Candice ; Park, Daniel ; Ballman, Claire ; Wallace, Meghan A ; Struttmann, Emily ; Stewart, Henry ; Arter, Olivia ; Peacock, Kate ; Fraser, Victoria J ; Budge, Philip J ; Olsen, Margaret A ; Burnham, Carey-Ann D ; Babcock, Hilary M ; Kwon, Jennie H ; CDC Prevention Epicenters ; for the CDC Prevention Epicenters</creatorcontrib><description>In a prospective cohort of healthcare personnel (HCP), we measured severe acute respiratory syndrome coronavirus virus 2 (SARS-CoV-2) nucleocapsid IgG antibodies after SARS-CoV-2 infection. Among 79 HCP, 68 (86%) were seropositive 14-28 days after their positive PCR test, and 54 (77%) of 70 were seropositive at the 70-180-day follow-up. Many seropositive HCP (95%) experienced an antibody decline by the second visit.</description><identifier>ISSN: 2732-494X</identifier><identifier>EISSN: 2732-494X</identifier><identifier>DOI: 10.1017/ash.2022.231</identifier><identifier>PMID: 36483363</identifier><language>eng</language><publisher>England: Cambridge University Press</publisher><subject>Concise Communication</subject><ispartof>Antimicrobial stewardship &amp; healthcare epidemiology : ASHE, 2022, Vol.2 (1), p.e93-e93, Article e93</ispartof><rights>The Author(s) 2022.</rights><rights>The Author(s) 2022 2022 The Author(s)</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c450t-50e95a84480f0a0ae8397bc78957d2606d28b44612aa9e7afff2721953aa4dc63</citedby><cites>FETCH-LOGICAL-c450t-50e95a84480f0a0ae8397bc78957d2606d28b44612aa9e7afff2721953aa4dc63</cites><orcidid>0000-0001-9015-8378 ; 0000-0002-4844-4212 ; 0000-0003-0767-5361 ; 0000-0001-6251-0733 ; 0000-0002-0069-2372 ; 0000-0001-7070-9320 ; 0000-0002-9307-4214 ; 0000-0003-2966-0750</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9726486/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9726486/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,4022,27922,27923,27924,37012,53790,53792</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36483363$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bosserman, Rachel E</creatorcontrib><creatorcontrib>Farnsworth, Christopher W</creatorcontrib><creatorcontrib>O'Neil, Caroline A</creatorcontrib><creatorcontrib>Cass, Candice</creatorcontrib><creatorcontrib>Park, Daniel</creatorcontrib><creatorcontrib>Ballman, Claire</creatorcontrib><creatorcontrib>Wallace, Meghan A</creatorcontrib><creatorcontrib>Struttmann, Emily</creatorcontrib><creatorcontrib>Stewart, Henry</creatorcontrib><creatorcontrib>Arter, Olivia</creatorcontrib><creatorcontrib>Peacock, Kate</creatorcontrib><creatorcontrib>Fraser, Victoria J</creatorcontrib><creatorcontrib>Budge, Philip J</creatorcontrib><creatorcontrib>Olsen, Margaret A</creatorcontrib><creatorcontrib>Burnham, Carey-Ann D</creatorcontrib><creatorcontrib>Babcock, Hilary M</creatorcontrib><creatorcontrib>Kwon, Jennie H</creatorcontrib><creatorcontrib>CDC Prevention Epicenters</creatorcontrib><creatorcontrib>for the CDC Prevention Epicenters</creatorcontrib><title>Antibodies in healthcare personnel following severe acute respiratory syndrome coronavirus virus 2 (SARS-CoV-2) infection</title><title>Antimicrobial stewardship &amp; healthcare epidemiology : ASHE</title><addtitle>Antimicrob Steward Healthc Epidemiol</addtitle><description>In a prospective cohort of healthcare personnel (HCP), we measured severe acute respiratory syndrome coronavirus virus 2 (SARS-CoV-2) nucleocapsid IgG antibodies after SARS-CoV-2 infection. Among 79 HCP, 68 (86%) were seropositive 14-28 days after their positive PCR test, and 54 (77%) of 70 were seropositive at the 70-180-day follow-up. Many seropositive HCP (95%) experienced an antibody decline by the second visit.</description><subject>Concise Communication</subject><issn>2732-494X</issn><issn>2732-494X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNpVkU1r3DAQhk1paUKaW8_FxxTqrTySLelSWJZ-BAKFpi29ibE82lXwSlvJ3rL_vt5uGpKLJGZenhn0FMXrmi1qVsv3mDcLYAAL4PWz4hwkh0po8ev5o_dZcZnzHWMMVM2kli-LM94KxXnLz4vDMoy-i72nXPpQbgiHcWMxUbmjlGMINJQuDkP848O6zLSnuYV2GqlMlHc-4RjTocyH0Ke4pdLGFAPufZpyeTqhvLpdfrutVvFnBW_nIY7s6GN4VbxwOGS6vL8vih-fPn5ffaluvn6-Xi1vKisaNlYNI92gEkIxx5AhKa5lZ6XSjeyhZW0PqhOirQFRk0TnHEiodcMRRW9bflFcn7h9xDuzS36L6WAievOvENPaYBq9HcjojgmEppNag3DMYUsgJdOCuV4rBTPrw4m1m7ot9ZbCmHB4An3aCX5j1nFvtIT5y4_LXN0DUvw9UR7N1mdLw4CB4pQNyIZzplgj5-i7U9SmmHMi9zCmZuYo38zyzVG-meXP8TePV3sI_1fN_wLe26wa</recordid><startdate>2022</startdate><enddate>2022</enddate><creator>Bosserman, Rachel E</creator><creator>Farnsworth, Christopher W</creator><creator>O'Neil, Caroline A</creator><creator>Cass, Candice</creator><creator>Park, Daniel</creator><creator>Ballman, Claire</creator><creator>Wallace, Meghan A</creator><creator>Struttmann, Emily</creator><creator>Stewart, Henry</creator><creator>Arter, Olivia</creator><creator>Peacock, Kate</creator><creator>Fraser, Victoria J</creator><creator>Budge, Philip J</creator><creator>Olsen, Margaret A</creator><creator>Burnham, Carey-Ann D</creator><creator>Babcock, Hilary M</creator><creator>Kwon, Jennie H</creator><general>Cambridge University Press</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0001-9015-8378</orcidid><orcidid>https://orcid.org/0000-0002-4844-4212</orcidid><orcidid>https://orcid.org/0000-0003-0767-5361</orcidid><orcidid>https://orcid.org/0000-0001-6251-0733</orcidid><orcidid>https://orcid.org/0000-0002-0069-2372</orcidid><orcidid>https://orcid.org/0000-0001-7070-9320</orcidid><orcidid>https://orcid.org/0000-0002-9307-4214</orcidid><orcidid>https://orcid.org/0000-0003-2966-0750</orcidid></search><sort><creationdate>2022</creationdate><title>Antibodies in healthcare personnel following severe acute respiratory syndrome coronavirus virus 2 (SARS-CoV-2) infection</title><author>Bosserman, Rachel E ; Farnsworth, Christopher W ; O'Neil, Caroline A ; Cass, Candice ; Park, Daniel ; Ballman, Claire ; Wallace, Meghan A ; Struttmann, Emily ; Stewart, Henry ; Arter, Olivia ; Peacock, Kate ; Fraser, Victoria J ; Budge, Philip J ; Olsen, Margaret A ; Burnham, Carey-Ann D ; Babcock, Hilary M ; Kwon, Jennie H</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c450t-50e95a84480f0a0ae8397bc78957d2606d28b44612aa9e7afff2721953aa4dc63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Concise Communication</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bosserman, Rachel E</creatorcontrib><creatorcontrib>Farnsworth, Christopher W</creatorcontrib><creatorcontrib>O'Neil, Caroline A</creatorcontrib><creatorcontrib>Cass, Candice</creatorcontrib><creatorcontrib>Park, Daniel</creatorcontrib><creatorcontrib>Ballman, Claire</creatorcontrib><creatorcontrib>Wallace, Meghan A</creatorcontrib><creatorcontrib>Struttmann, Emily</creatorcontrib><creatorcontrib>Stewart, Henry</creatorcontrib><creatorcontrib>Arter, Olivia</creatorcontrib><creatorcontrib>Peacock, Kate</creatorcontrib><creatorcontrib>Fraser, Victoria J</creatorcontrib><creatorcontrib>Budge, Philip J</creatorcontrib><creatorcontrib>Olsen, Margaret A</creatorcontrib><creatorcontrib>Burnham, Carey-Ann D</creatorcontrib><creatorcontrib>Babcock, Hilary M</creatorcontrib><creatorcontrib>Kwon, Jennie H</creatorcontrib><creatorcontrib>CDC Prevention Epicenters</creatorcontrib><creatorcontrib>for the CDC Prevention Epicenters</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>Directory of Open Access Journals</collection><jtitle>Antimicrobial stewardship &amp; healthcare epidemiology : ASHE</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bosserman, Rachel E</au><au>Farnsworth, Christopher W</au><au>O'Neil, Caroline A</au><au>Cass, Candice</au><au>Park, Daniel</au><au>Ballman, Claire</au><au>Wallace, Meghan A</au><au>Struttmann, Emily</au><au>Stewart, Henry</au><au>Arter, Olivia</au><au>Peacock, Kate</au><au>Fraser, Victoria J</au><au>Budge, Philip J</au><au>Olsen, Margaret A</au><au>Burnham, Carey-Ann D</au><au>Babcock, Hilary M</au><au>Kwon, Jennie H</au><aucorp>CDC Prevention Epicenters</aucorp><aucorp>for the CDC Prevention Epicenters</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Antibodies in healthcare personnel following severe acute respiratory syndrome coronavirus virus 2 (SARS-CoV-2) infection</atitle><jtitle>Antimicrobial stewardship &amp; healthcare epidemiology : ASHE</jtitle><addtitle>Antimicrob Steward Healthc Epidemiol</addtitle><date>2022</date><risdate>2022</risdate><volume>2</volume><issue>1</issue><spage>e93</spage><epage>e93</epage><pages>e93-e93</pages><artnum>e93</artnum><issn>2732-494X</issn><eissn>2732-494X</eissn><abstract>In a prospective cohort of healthcare personnel (HCP), we measured severe acute respiratory syndrome coronavirus virus 2 (SARS-CoV-2) nucleocapsid IgG antibodies after SARS-CoV-2 infection. Among 79 HCP, 68 (86%) were seropositive 14-28 days after their positive PCR test, and 54 (77%) of 70 were seropositive at the 70-180-day follow-up. Many seropositive HCP (95%) experienced an antibody decline by the second visit.</abstract><cop>England</cop><pub>Cambridge University Press</pub><pmid>36483363</pmid><doi>10.1017/ash.2022.231</doi><orcidid>https://orcid.org/0000-0001-9015-8378</orcidid><orcidid>https://orcid.org/0000-0002-4844-4212</orcidid><orcidid>https://orcid.org/0000-0003-0767-5361</orcidid><orcidid>https://orcid.org/0000-0001-6251-0733</orcidid><orcidid>https://orcid.org/0000-0002-0069-2372</orcidid><orcidid>https://orcid.org/0000-0001-7070-9320</orcidid><orcidid>https://orcid.org/0000-0002-9307-4214</orcidid><orcidid>https://orcid.org/0000-0003-2966-0750</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2732-494X
ispartof Antimicrobial stewardship & healthcare epidemiology : ASHE, 2022, Vol.2 (1), p.e93-e93, Article e93
issn 2732-494X
2732-494X
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_9b04a25b79924f0fa6e2770940fd9882
source Open Access: PubMed Central; Cambridge Journals Online; Publicly Available Content Database
subjects Concise Communication
title Antibodies in healthcare personnel following severe acute respiratory syndrome coronavirus virus 2 (SARS-CoV-2) infection
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-12T01%3A38%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Antibodies%20in%20healthcare%20personnel%20following%20severe%20acute%20respiratory%20syndrome%20coronavirus%20virus%202%20(SARS-CoV-2)%20infection&rft.jtitle=Antimicrobial%20stewardship%20&%20healthcare%20epidemiology%20:%20ASHE&rft.au=Bosserman,%20Rachel%20E&rft.aucorp=CDC%20Prevention%20Epicenters&rft.date=2022&rft.volume=2&rft.issue=1&rft.spage=e93&rft.epage=e93&rft.pages=e93-e93&rft.artnum=e93&rft.issn=2732-494X&rft.eissn=2732-494X&rft_id=info:doi/10.1017/ash.2022.231&rft_dat=%3Cproquest_doaj_%3E2753308057%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c450t-50e95a84480f0a0ae8397bc78957d2606d28b44612aa9e7afff2721953aa4dc63%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2753308057&rft_id=info:pmid/36483363&rfr_iscdi=true